Our Team Category: Scientific and Corporate Advisors

The Insight Drop | PD-1/VEGF Bispecifics: From China-Driven Breakthrough to Global Reality Check

The Insight Drop | Cell Therapy in Multiple Sclerosis: A Market Signal in Search of Proof

5 Portfolio Management Lessons Learned from the Strategic PPM for Pharma Conference

The Insight Drop | Regulatory Designations in Oncology: Signal or Substance?

The Insight Drop | Line of Treatment: A Strategic Lever in Oncology Drug Development

De-Risking Oncology Combination Therapies with Data-Driven Insight